69th scientific sessions of the American Heart Association

A H Danser1, A MaassenVanDenBrink, C A van Kesteren

  • 1Department of Pharmacology, Erasmus University, Dr. Molewaterplein 50, 3015 GE Rotterdam, The Netherlands.

Insights

The American Heart Association

Area of Science:

  • Cardiovascular Science
  • Clinical Cardiology
  • Biomedical Research

Background:

  • The American Heart Association (AHA) Scientific Sessions is a premier global event for cardiovascular professionals.
  • Abstracts submitted undergo a rigorous selection process to ensure high-quality scientific content.
  • The 69th Scientific Sessions showcased cutting-edge research in cardiovascular disease.

Purpose of the Study:

  • To present a summary of the abstracts selected for the 69th AHA Scientific Sessions.
  • To highlight the breadth and depth of research presented at the conference.
  • To provide a reference for the published abstracts in Circulation.

Main Methods:

  • Over 12,000 abstracts were submitted for consideration.
  • A selection committee reviewed and curated submissions.
  • 4,359 abstracts were accepted for presentation.

Main Results:

  • A total of 4,359 abstracts were selected from over 12,000 submissions.
  • These selected abstracts represent significant advancements in cardiovascular science.
  • The abstracts are published in a supplement to Circulation (Vol. 94, No. 8).

Conclusions:

  • The 69th AHA Scientific Sessions featured a substantial body of high-impact cardiovascular research.
  • The published abstracts serve as a valuable resource for the scientific community.
  • The selection process ensures the presentation of leading-edge cardiovascular science.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...